Noubar Afeyan

Founder and CEO

2000 - Current

Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. To date, Flagship has deployed over $3.4 billion in capital toward the founding and growth of its pioneering companies alongside more than $26 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 40 companies, including Denali Therapeutics (NASDAQ: DNLI), Foghorn Therapeutics (NASDAQ: FHTX), Generate:Biomedicines, Inari, Indigo Agriculture, Moderna (NASDAQ: MRNA), Omega Therapeutics (NASDAQ: OMGA), Sana Biotechnology (NASDAQ: SANA), Seres Therapeutics (NASDAQ: MCRB) and Tessera Therapeutics.

Member of Executive Committee, MIT Corporation

2016

Co-Founder and Chairman

2010

Co-Founder and Chairman

2018

Co-Founder and Board Member

2018

Co-Founder and Board Member

2024

Co-Founder and Chairman

2021

Co-founder and Chairman

2022

Founding Chairman

2021

Co-Founder and Board Member

2014

Aurora Prize for Awakening Humanity is an annual international humanitarian award, which is initiated to recognize and express gratitude to those courageous individuals or organizations that impact on preserving human life and advancing humanitarian causes. It is awarded on behalf of the survivors of the Armenian Genocide and in gratitude to their saviors. The Aurora Prize ceremonies take place annually in Yerevan, Armenia starting from 24 April 2016. The laureate of the prize receives $100,000 grant as well as the opportunity to nominate organizations that inspired his or her work for a US $1,000,000 award (from Wikipedia).